Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome

G. Grassi, R. Dell'Oro, F. Quarti-Trevano, F. Scopelliti, G. Seravalle, F. Paleari, P. L. Gamba, G. Mancia

Research output: Contribution to journalArticlepeer-review


Aims/hypothesis: Previous studies have shown that alterations in vascular, metabolic, inflammatory and haemocoagulative functions characterise the metabolic syndrome. Whether this is also the case for sympathetic function is not clear. We therefore aimed to clarify this issue and to determine whether metabolic or reflex mechanisms might be responsible for the possible adrenergic dysfunction. Methods: In 43 healthy control subjects (age 48.2±1.0 years, mean±SEM) and in 48 untreated age-matched subjects with metabolic syndrome (National Cholesterol Education Program's Adult Treatment Panel III Report criteria) we measured, along with anthropometric and metabolic variables, blood pressure (Finapres), heart rate (ECG) and efferent postganglionic muscle sympathetic nerve activity (microneurography) at rest and during baroreceptor manipulation (vasoactive drug infusion technique). Results: Compared with control subjects, subjects with metabolic syndrome had higher BMI, waist circumference, blood pressure, cholesterol, triglycerides, insulin and homeostasis model assessment (HOMA) index values but lower HDL cholesterol values. Sympathetic nerve traffic was significantly greater in subjects with metabolic syndrome than in control subjects (61.1±2.6 vs 43.8±2.8 bursts/100 heartbeats, p

Original languageEnglish
Pages (from-to)1359-1365
Number of pages7
Issue number7
Publication statusPublished - Jul 2005


  • Baroreceptor
  • Insulin
  • Metabolic syndrome
  • Obesity
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine


Dive into the research topics of 'Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome'. Together they form a unique fingerprint.

Cite this